COPD promotes migration of A549 lung cancer cells: The role of chemokine CCL21

International Journal of COPD

Volumn 11, Issue 1, 2016, Pages 1061-1066

  Kuźnar Kamińska, Barbara ^a   Mikuła Pietrasik, Justyna ^b   Sosińska, Patrycja ^b   Książek, Krzysztof ^b   Batura Gabryel, Halina ^a  

^a Allergology and Respiratory Oncology ^*  (Poland)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Chemokines; COPD; Lung cancer; Migration

Indexed keywords

EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; SECONDARY LYMPHOID TISSUE CHEMOKINE; STROMAL CELL DERIVED FACTOR 1; CCL21 PROTEIN, HUMAN;

A549 CELL LINE; ADULT; ARTICLE; BLOOD SAMPLING; CANCER GROWTH; CANCER MORTALITY; CANCER RISK; CELL MIGRATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; HUMAN CELL; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN FUNCTION; SMOKING HABIT; A-549 CELL LINE; AGED; CARCINOMA, NON-SMALL-CELL LUNG; CELL MOTION; COMPLICATION; LUNG NEOPLASMS; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; SECONDARY;

A549 CELLS; AGED; CARCINOMA, NON-SMALL-CELL LUNG; CELL MOVEMENT; CHEMOKINE CCL21; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84969963395     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S96490     Document Type: Article

References (27)

1. Young RP, Hopkins RJ, Gamble GD. Clinical applications of gene-based risk prediction for lung cancer and the central role of chronic obstructive pulmonary disease. Front Genet. 2012;3:210.
2. Chia CY, Kumari U, Casey PJ. Breast cancer cell invasion mediated by Galpha12 signaling involves expression of interleukins-6 and -8, and matrix metalloproteinase-2. J Mol Signal. 2014;9:6.
3. Li Z, Wang Y, Dong S, et al. Association of CXCR1 and 2 expressions with gastric cancer metastasis in ex vivo and tumor cell invasion in vitro. Cytokine. 2014;69(1):6–13.
4. Li Z, Zhang LJ, Zhang HR, et al. Tumor-derived transforming growth factor-beta is critical for tumor progression and evasion from immune surveillance. Asian Pac J Cancer Prev. 2014;15(13):5181–5186.
5. Mak M, Spill F, Kamm RD, Zaman MH. Single-cell migration in complex microenvironments: mechanics and signaling dynamics. J Biomech Eng. 2016;138(2).
6. Hager A, Alexander S, Friedl P. Cancer invasion and resistance. EJC Suppl. 2013;11(2):291–293.
7. Barnes PJ. The cytokine network in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol. 2009;41(6):631–638.
8. Wang ZL. Association between chronic obstructive pulmonary disease and lung cancer: the missing link. Chin Med J (Engl). 2013;126(1):154–165.
9. Hsu YL, Hou MF, Kuo PL, Huang YF, Tsai EM. Breast tumor-associated osteoblast-derived CXCL5 increases cancer progression by ERK/MSK1/Elk-1/snail signaling pathway. Oncogene. 2013;32(37):4436–4447.
10. Liu Y, Ji R, Li J, et al. Correlation effect of EGFR and CXCR4 and CCR7 chemokine receptors in predicting breast cancer metastasis and prognosis. J Exp Clin Cancer Res. 2010;29:16.
11. Berndt B, Haverkampf S, Reith G, et al. Fusion of CCL21 non-migratory active breast epithelial and breast cancer cells give rise to CCL21 migratory active tumor hybrid cell lines. PLoS One. 2013;8(5):e63711.
12. Wald O, Izhar U, Amir G, et al. Interaction between neoplastic cells and cancer-associated fibroblasts through the CXCL12/CXCR4 axis: role in non-small cell lung cancer tumor proliferation. J Thorac Cardiovasc Surg. 2011;141(6):1503–1512.
13. Xu Y, Liu L, Qiu X, et al. CCL21/CCR7 promotes G2/M phase progression via the ERK pathway in human non-small cell lung cancer cells. PLoS One. 2011;6(6):e21119.
14. Ben-Baruch A. Organ selectivity in metastasis: regulation by chemokines and their receptors. Clin Exp Metastasis. 2008;25(4):345–356.
15. Han N, Yuan X, Wu H, et al. DACH1 inhibits lung adenocarcinoma invasion and tumor growth by repressing CXCL5 signaling. Oncotarget. 2015;6(8):5877–5888.
16. Miller YE. Pathogenesis of lung cancer: 100 year report. Am J Respir Cell Mol Biol. 2005;33(3):216–223.
17. Friedl P, Wolf K. Plasticity of cell migration: a multiscale tuning model. J Cell Biol. 2010;188(1):11–19.
18. Foster KA, Oster CG, Mayer MM, Avery ML, Audus KL. Characterization of the A549 cell line as a type II pulmonary epithelial cell model for drug metabolism. Exp Cell Res. 1998;243(2):359–366.
19. Katakura Y. Molecular basis for the cellular senescence program and its application to anticancer therapy. Biosci Biotechnol Biochem. 2006;70(5):1076–1081.
20. Jung MJ, Rho JK, Kim YM, et al. Upregulation of CXCR4 is functionally crucial for maintenance of stemness in drug-resistant non-small cell lung cancer cells. Oncogene. 2013;32(2):209–221.
21. Maekawa S, Iwasaki A, Shirakusa T, et al. Association between the expression of chemokine receptors CCR7 and CXCR3, and lymph node metastatic potential in lung adenocarcinoma. Oncol Rep. 2008;19(6):1461–1468.
22. Saintigny P, Massarelli E, Lin S, et al. CXCR2 expression in tumor cells is a poor prognostic factor and promotes invasion and metastasis in lung adenocarcinoma. Cancer Res. 2013;73(2):571–582.
23. Fry JS, Lee PN, Forey BA, Coombs KJ. How rapidly does the excess risk of lung cancer decline following quitting smoking? A quantitative review using the negative exponential model. Regul Toxicol Pharmacol. 2013;67(1):13–26.
24. Westmaas JL, Newton CC, Stevens VL, Flanders WD, Gapstur SM, Jacobs EJ. Does a recent cancer diagnosis predict smoking cessation? An analysis from a large prospective US cohort. J Clin Oncol. 2015;33(15):1647–1652.
25. Wasswa-Kintu S, Gan WQ, Man SF, Pare PD, Sin DD. Relationship between reduced forced expiratory volume in one second and the risk of lung cancer: a systematic review and meta-analysis. Thorax. 2005;60(7):570–575.
26. Kawamura M, Toiyama Y, Tanaka K, et al. CXCL5, a promoter of cell proliferation, migration and invasion, is a novel serum prognostic marker in patients with colorectal cancer. Eur J Cancer. 2012;48(14):2244–2251.
27. Keeley EC, Mehrad B, Strieter RM. Chemokines as mediators of tumor angiogenesis and neovascularization. Exp Cell Res. 2011;317(5):685–690.